| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Yield10 Bioscience (NASDAQ:YTEN) reported its Q4 earnings results on Monday, April 1, 2024 at 04:01 PM.
Here's what investors need to know about the announcement.
Yield10 Bioscience beat estimated earnings by 10.0%, reporting an EPS of $-0.27 versus an estimate of $-0.3.
Revenue was down $87 thousand from the same period last year.
Last quarter the company missed on EPS by $0.02 which was followed by a 15.0% drop in the share price the next day.
Here's a look at Yield10 Bioscience's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.39 | -0.54 | -0.63 | -0.60 |
| EPS Actual | -0.41 | -0.64 | -0.76 | -0.67 |
| Revenue Estimate | 70K | 30K | 70K | 120K |
| Revenue Actual | 0 | 0 | 60K | 87K |
To track all earnings releases for Yield10 Bioscience visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: YTEN
